Amwell (AMWL) Tops Q2 EPS by 4c

Amwell (NYSE: AMWL) reported Q2 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $60.2 million versus the consensus estimate of $61.7 million.

GUIDANCE:

Amwell sees FY2021 revenue of $252-262 million, versus the consensus of $263 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Pfizer lung cancer drug misses survival goal in Phase 3 trial